• English
  • 中文繁体
  • 中文简体
Hi,
moomoo ID:NaN
Log Out

Download App

Log in to access Online Inquiry
Quotes
Detailed Quotes
Company Overview
Company ProfileCompany Executives
Financial Analysis
Main CompositionKey IndicatorsFinancial Statement
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Company Overview More
China Shenwei Pharmaceutical Group Co., Ltd. is an investment holding company, mainly engaged in R & D, manufacturing and marketing of modern traditional Chinese medicine. Its main products include injection, soft capsule and granule. The company's subsidiaries include Broad International Co., Ltd., Hongzhan International Co., Ltd. And Shenwei Pharmaceutical Marketing Co., Ltd.
CEO： Zhenjiang Li
Market： Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > 02877 SHINEWAY PHARM > Financial Statement > Balance sheet
02877 SHINEWAY PHARM
5.920+0.050+0.85%
Income statement Balance sheet Cash flow
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Assets
Current assets
Inventory
32.72% 587.96M -2.33% 434.08M 2.83% 443M 25.29% 444.44M
Accounts receivable
36.13% 424.46M 26.82% 401.24M 19.91% 311.79M 29.21% 316.38M
Advance deposits and other receivables
10.97% 80.25M -42.13% 87.35M -52.23% 72.32M 40.25% 150.95M
Withholding and tax receivable
-- -- -- -- -- 48K -- --
Cash and equivalents
6.66% 4.21B 1.68% 4.15B -0.08% 3.94B 15.15% 4.08B
Secured deposit
-- -- -- -- 55662.08% 300M 5102.91% 300M
Financial assets at fair value-current assets
-- -- -- 22.62M -- -- -- --
Special items of current assets
-10.73% 400.73M 21.7% 370.57M 8.35% 448.87M -22.18% 304.49M
Total current assets
3.26% 5.7B -2.36% 5.47B 6.07% 5.52B 20.41% 5.6B
Non-current assets
Property, plant and equipment
-10.24% 1.25B -8.31% 1.3B -6.64% 1.39B -6.84% 1.42B
Advance payment
-- -- -- -- -- 137.14M -- --
Intangible assets
79.73% 66.43M -66.53% 75.97M -85.11% 36.96M -14.88% 226.95M
Goodwill
61.91% 165.96M 4.18% 165.96M -35.65% 102.5M 0% 159.29M
Deferred tax assets
-11.42% 20.47M -19.74% 19.42M -13.8% 23.1M -6.11% 24.19M
Total non-current assets
-11.19% 1.5B -14.59% 1.57B -12.13% 1.69B -9.02% 1.83B
Total assets
-0.13% 7.2B -5.37% 7.03B 1.15% 7.21B 11.51% 7.43B
Liabilities
Current liabilities
Accounts payable
39.08% 228.62M 8.32% 146.03M -13.23% 164.38M -13.18% 134.81M
Tax payable
11.52% 65.1M 22.66% 41.24M 47.84% 58.37M -10.16% 33.62M
Amounts payable to associated parties-current liabilities
-6.76% 13.78M -6.76% 13.78M -7.22% 14.78M -7.22% 14.78M
Other payables and accrued expenses
32.81% 666.23M 15.29% 588.04M 16.87% 501.63M 7.39% 510.07M
Bank loans and overdrafts
-- -- -- -- -7.3% 369.32M -- 609.8M
Financial lease liabilities-current liabilities
-2.62% 7.59M 181.9% 7.98M 67.26% 7.79M -23.17% 2.83M
Deferred income-current liabilities
189.95% 31.17M 95.65% 22.2M -79.95% 10.75M -71.15% 11.35M
Special items of current liabilities
26.91% 85.89M 18.29% 59.76M 43.16% 67.67M 48.09% 50.52M
Total current liabilities
-8.06% 1.1B -35.73% 879.04M 1.42% 1.19B 79.8% 1.37B
Net current assets
6.39% 4.6B 8.43% 4.59B 7.44% 4.32B 8.79% 4.23B
Total assets less current liabilities
1.44% 6.11B 1.47% 6.15B 1.1% 6.02B 2.72% 6.07B
Non-current liabilities
Financial lease liabilities-non-current liabilities
-51.26% 7.32M 958.09% 10.98M 910.63% 15.03M -45.57% 1.04M
Deferred tax liability
375.51% 25.19M -46.36% 18.11M -88.73% 5.3M -16.09% 33.76M
Deferred income-non-current liabilities
-16.01% 171.59M -8.7% 177.54M 59.71% 204.31M 49.79% 194.45M
Total non-current liabilities
-9.14% 204.11M -9.87% 206.63M 27.34% 224.63M 33.32% 229.25M
Total liabilities
-8.23% 1.3B -32.02% 1.09B 4.79% 1.42B 71.23% 1.6B
Total assets less total liabilities
1.85% 5.9B 1.92% 5.95B 0.3% 5.79B 1.8% 5.84B
Total equity and non-current liabilities
1.44% 6.11B 1.47% 6.15B 1.1% 6.02B 2.72% 6.07B
Equity
Share capital
0% 87.66M 0% 87.66M 0% 87.66M 0% 87.66M
Reserve
1.88% 5.81B 1.95% 5.86B 0.3% 5.71B 1.83% 5.75B
Legal reserve
1.88% 5.81B 1.95% 5.86B 0.3% 5.71B 1.83% 5.75B
Shareholders' Equity
1.85% 5.9B 1.92% 5.95B 0.3% 5.79B 1.8% 5.84B
Total equity
1.85% 5.9B 1.92% 5.95B 0.3% 5.79B 1.8% 5.84B
Total equity and total liabilities
-0.13% 7.2B -5.37% 7.03B 1.15% 7.21B 11.51% 7.43B
Currency Unit
CNYCNYCNYCNY
Accounting Standards
IASIASIASIAS
Audit Opinions
Unqualified Opinion--Unqualified Opinion--
Auditor
Deloitte Guan Huang Chen Fang Accountants--Deloitte Guan Huang Chen Fang Accountants--

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%